Table (1).
The levels of hemoglobin, activities of serum CK;MB, LDH1 and AST in All studied groups (mean ±SD)
| Patients Groups | Control n=20 |
MI n=20 |
Thalass. n=20 |
MI +Thalass. n=20 |
| Parameters | ||||
| Hemoglobin (g/dl) Mean±SD P1 value P2 value |
15.3± 2.1 --- --- |
14.3±2.4 <0.001 --- |
9.5± 1.2 <0.001 <0.001 |
10.1± 1.1 <0.001 <0.05 |
| CK:MB (U/L) Mean±SD P1 value P2 value |
33.8 ±4.02 --- --- |
67.5±5.06 <0.001 --- |
31.1± 3.2 <0.001 <0.01 |
50.3± 5.18 <0.001 <0.01 |
| LDH1 (U/L) Mean±SD P1 value P2 value |
62±4.5 --- --- |
84±8.7 <0.05 --- |
55± 5.8 N.S --- |
90.± 9.9 <0.001 <0.001 |
| AST (U/L) Mean±SD P1 value P2 value |
22± 2.02 --- --- |
81±9.12 <0.001 <0.001 |
32+ 3 N.S --- |
65± 4 <0.001 <0.001 |
n = number of cases p1 value, thalassemia, Myocardial infarction and thalassemia with Myocardial infarction versus control. p2 value, thalassemia with Myocardial infarction versus Myocardial infarction